Open access · OA
via Europe PMC
Micronutrition as a Therapeutic Strategy for Mitochondrial Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Fibromyalgia: A Narrative Review.
Abanades S, Fernández I, Capdevila N, Cardona F.
Nutrients · 2026
Abstract
Fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) are chronic multisystem disorders characterized by persistent fatigue, pain, cognitive dysfunction, sleep disturbances, and reduced quality of life. Increasing evidence implicates mitochondrial dysfunction(definition), oxidative and nitrosative stress, immune dysregulation, and altered redox and nicotinamide adenine dinucleotide (NAD<sup>+</sup>) metabolism as interconnected mechanisms contributing to fatigue, although the strength of evidence varies across these pathways. Micronutrients are essential components of mitochondrial bioenergetics, antioxidant defense, and immune-metabolic regulation. This narrative review critically examines the mechanistic and clinical evidence supporting mitochondrial-oriented micronutritional interventions in fibromyalgia and ME/CFS, including NAD<sup>+</sup> precursors, B-complex vitamins, magnesium, coenzyme Q10, alpha-lipoic acid, GlyNAC, L-carnitine, pyrroloquinoline quinone, taurine, and creatine. Mechanistic plausibility is distinguished from clinical efficacy, as disease-specific randomized controlled evidence remains limited for several interventions. We further discuss biomarkers, metabolic phenotyping, and precision nutrition within a systems-based micronutrition framework. Finally, we present the rationale for a future randomized, double-blind, placebo-controlled trial in fibromyalgia patients with clinically significant fatigue, which is planned for 2027, subject to ethics approval and prospective registration, as a strategy for future clinical validation.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.3390/nu18162702
- Canonical
- link ↗
- Fetched
- 2026-10-06 MST
Cite this
APA
S, A., I, F., N, C., & F., C. (2026). Micronutrition as a Therapeutic Strategy for Mitochondrial Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Fibromyalgia: A Narrative Review. <em>Nutrients</em>. https://doi.org/10.3390/nu18162702
Vancouver
S A, I F, N C, F. C. Micronutrition as a Therapeutic Strategy for Mitochondrial Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Fibromyalgia: A Narrative Review. Nutrients. 2026. doi:10.3390/nu18162702.
BibTeX
@article{abanades2026Micron,
title = {Micronutrition as a Therapeutic Strategy for Mitochondrial Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Fibromyalgia: A Narrative Review.},
author = {Abanades S and Fernández I and Capdevila N and Cardona F.},
journal = {Nutrients},
year = {2026},
doi = {10.3390/nu18162702},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
2025
Open access · CC-BY
THE ROLE OF NAD⁺ AND ITS DERIVATIVES IN METABOLISM AND AGING
Aging and Disease 2022
Open access · CC-BY
The Role of Kynurenine Pathway and NAD+ Metabolism in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Cosmetics 2025
Open access · CC-BY
Oral Supplementation of Nicotinamide Mononucleotide (NMN) Improves Hair Quality and Subjective Perception of Hair Appearance in Middle-Aged Women
Molecular biology reports 2026
Open access · OA
NAD⁺ biology and supplementation: From mechanisms to clinical perspectives.
Frontiers in pharmacology 2026
Open access · OA
Mechanistic intersections of empagliflozin and nebivolol in aging-associated redox and inflammatory pathways.
The Yale journal of biology and medicine 2026
Open access · OA